… [3] and the guidelines of the European Society of Endocrinology for the management of
aggressive pituitary tumours and carcinomas [4, 5] have established criteria for stratifying a …

… studies on bevacizumab for aggressive pituitary adenomas or carcinomas do not go beyond
… line treatment in three cases of aggressive pituitary tumors, having all undergone multiple …

… in the course of disease (7). PCs are extremely rare accounting for only 0.12% of pituitary
tumors (8). The use of temozolomide (TMZ) for the treatment of aggressive pituitary tumors (…

… In this review, we present 9 cases of aggressive pituitary adenomas to illustrate the importance
of … A systematic review of TMZ in aggressive pituitary adenomas and carcinomas showed …

… , it was reported that patients with APT have a clinical course rather similar to pituitary
carcinomas (ie, pituitary tumors with craniospinal or systemic metastases) with a mortality rate of 28…

… many tumors, including pituitary tumors. The purpose of this review is to report the progress
of immunotherapy in pituitary tumors, including refractory PAs and PCs. The tumor immune …

… of ipilimumab and nivolumab in patients with aggressive pituitary tumors (NCT04042753) or
various rare tumors including pituitary carcinomas (NCT02834013). Of particular similarity to …

… Aggressive pituitary adenoma (APA) refers to a tumor that is both invasive and proliferative or
displays clinically meaningful tumor … Pituitary carcinomas (PCs) are exceedingly rare with a …

… tumors had some degree of CCs. Predictors of clinical behavior in CCAs and other aggressive
… We present a case with a pituitary adenoma with multiple resections and local stereotactic …

… of a significant number of pituitary tumors. In fact, pituitary tumors are often invasive neoplasms
that can infiltrate into surrounding structures, not unlike carcinomas. Moreover, when they …